CareSelect Imaging Open Access web portal
The CareSelect® Imaging Open Access web portal delivers a combination of Appropriate Use Criteria (AUC) published by qualified provider-led entities (qPLE) including the American College of Radiology, the American College of Cardiology Foundation, the National Comprehensive Cancer Network, and the Society for Nuclear Medicine and Molecular Imaging and is fully qualified for use as a qualified clinical decision support mechanism (qCDSM) under PAMA.
Enable widespread AUC access
Easy access for providers and their proxies
CareSelect Imaging Open Access enables providers and their proxies to seamlessly consult AUC for ordering guidance in imaging exams.
Provider access and consultation
To access the portal, providers must register with their NPI and organizational information. Once registered, providers will gain immediate portal access and be able to generate compliant consultations.
Proxy access
Clinical staff can act as ordering proxies under the direction of an ordering provider. Clinical staff members need to create their own Open Access accounts and utilize the “Change Ordering Provider” functionality within the web application to consult on a provider’s behalf. This functionality allows for the proxy staff member to attribute the consultation to a provider’s NPI.
Key benefits
Make compliance easy for providers and proxies.
Get no-charge provider access
Streamline the referral segment of the radiology market and eliminate the need for duplicate CDSM consultation.
Simplify communication
CDS consultations are visible on both the provider and proxy dashboards.
Related healthcare insights
Video
Hear how the industry’s most transparent and independent Pharmacy & Therapeutics Committee evaluates drugs for the Optum Rx formulary.
On-demand webinar
Discover how to leverage automation for centralized, exception-based utilization management.
Article
Learn more about why evidence-based criteria and clinician insight are needed for informed and trustworthy decisions while leveraging AI.
